Profitable Fintech, Fino Payments Bank’s IPO sees positive response from retail investors; Issue subscribed 51% on Day 1

-

Profitable Fintech, Fino Payments Bank’s IPO sees positive response from retail investors; Issue subscribed 51% on Day 1

Mumbai, October 29th, 2021: Fino Payments Bank Limited (“Company”); one of the growing fintech company offering a diverse range of financial products and services that are primarily digital and have a payments focus, received bids of 58,13,975 shares against the offered 1,14,64,664 equity shares, as per the 5:00 pm data available on the bourses.

 The portion reserved for retail investors was subscribed 2.73 times and the Non-Institutional Investor category was subscribed 0.05 times and Employee Reserved category was subscribed 0.25 times, while the Qualified Institutional Buyer category didn’t see any response on Day 1.

 The Offer comprises of a fresh issuance of equity shares aggregating up to Rs 300 Cr (“Fresh Issue”) and an offer for sale of up to 15,602,999 equity shares by selling shareholders. The Company proposes to utilize the net proceeds from the fresh issue towards augmenting the bank’s tier-1 capital base to meet its future capital requirements.

 The Company raised Rs. 538 crore from 29 anchor investors. As per the exchange, the investors includes Fidelity, HSBC Global, Pinebridge, Birla Mutual Fund, Motilal Oswal, TATA Mutual Fund, SBI Life, Invesco, BNP Paribas and Societe Generale.

 Axis Capital Ltd, CLSA India Pvt Ltd, ICICI Securities Ltd, and Nomura Financial Advisory Services Pvt Ltd are the Book Running Lead Managers to the Offer

Comments

Post a Comment

Popular posts from this blog

Indegene acquires Trilogy Writing & Consulting GmbH, a medical writing consultancy

-
  Indegene acquires Trilogy Writing & Consulting GmbH,  a medical writing consultancy   India, March 27, 2024:  Indegene, a  digital-first, life sciences commercialization company , announced the acquisition of Trilogy Writing & Consulting GmbH (Trilogy), a global provider of specialty medical writing capabilities across clinical, regulatory, safety and medical content to life sciences companies. The acquisition by Indegene Ireland, a subsidiary of Indegene Limited, augments Indegene’s depth of clinical and regulatory writing expertise for market authorization applications globally.   Trilogy Writing & Consulting is a Germany, UK, and US-based, medical writing consultancy with know-how in the development and delivery of clinical, regulatory, safety, and medical content. It applies its expertise and unique approaches to deliver quality medical writing output. Trilogy has a proven track record of more than 22 years of providing medical writing ser...
Read more

After Abida Parveen & Atif Aslam's magical performance, Next is Enrique Iglesias who is all set to perform in UAE

-
Image
  After Abida Parveen & Atif Aslam's magical performance, Next is Enrique Iglesias who is all set to perform in UAE After the massive success of the unprecedented and unique collaboration named ‘Symphony of Stars,’ featuring Abida Parveen and Atif Aslam together recently, the leading lifestyle management company Blu Blood is all set to bring the global pop sensation Enrique Iglesias to the Coca-Cola Arena in Dubai on September 13th, 2024. When the legendary music icons Abida Parveen and Atif Aslam shared the stage, the audience witnessed something truly breathtaking and unforgettable. The concert stood out from the ordinary, as fans went wild on social media, sharing numerous posts detailing their once-in-a-lifetime experiences and concert clips that touched the hearts of many, quickly going viral. It has entertained fans across the country, and now Blu Blood promises to deliver the same epic musical extravaganza with the Latin megastar Enrique Iglesias for the very first time....
Read more